SCHEMBL871044

SCHEMBL871044

CCn1c2ccccc2c2cc(Br)ccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.65
KDM4E B2RXH2 7/20 0.65
MEN1 O00255 5/20 0.65
KMT2A Q03164 5/20 0.65
ALDH1A1 P00352 3/20 0.65
HTT P42858 2/20 0.65
MAPK1 P28482 2/20 0.65
HPGD P15428 2/20 0.65
HBB P68871 1/20 0.65
HSD17B10 Q99714 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
TP53 P04637 2/20 0.63
TSPO P30536 2/20 0.61
LMNA P02545 5/20 0.56
POLB P06746 3/20 0.55
PKM P14618 1/20 0.55
PTGER4 P35408 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SRC P12931 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29773622 1.00 MAPT (0.65) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL871702 0.91 MAPT (0.55) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL29429155 0.91 MAPT (0.55) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL2584799 0.89 MAPT (0.56) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL18187578 0.88 MAPT (0.52) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL1921157 0.86 ALDH1A1 (0.60) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL2269351 0.84 MAPT (0.55) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL20664735 0.84 MAPT (0.59) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL12395043 0.84 PTGER4 (0.49) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL23780637 0.83 TSPO (0.52) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113462381-A Polar sensitive NIR probe with high binding force with amyloid fiber and preparation and application thereof 首都师范大学 2021-10-01 CN claimed
CN-109053549-B Two-photon fluorescent probe for positioning mitochondria to detect viscosity and synthetic method and application thereof 济南大学 2020-08-11 CN claimed
CN-122057035-A Pharmaceutical composition and application thereof in preparation of tumor treatment drugs 山东大学 2026-05-19 CN disclosed
US-20260098188-A1 RELEASE AGENT COMPOSITION FOR LIGHT IRRADIATION RELEASE, AND ADHESIVE COMPOSITION FOR LIGHT IRRADIATION RELEASE NISSAN CHEMICAL CORPORATION (JP) 2026-04-09 US disclosed
EP-4678709-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 EP disclosed
EP-4678708-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2026-01-14 EP disclosed
US-20260011598-A1 RELEASE AGENT COMPOSITION FOR PHOTOIRRADIATION RELEASE, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE NISSAN CHEMICAL CORPORATION (JP) 2026-01-08 US disclosed
CN-121248474-A Method for synthesizing 3-bromo-9-ethylcarbazole by reactive extrusion 西安近代化学研究所 2026-01-02 CN disclosed
CN-121248474-A Method for synthesizing 3-bromo-9-ethylcarbazole by reactive extrusion 西安近代化学研究所 2026-01-02 CN disclosed
EP-4653507-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2025-11-26 EP disclosed
EP-4653508-A1 ADHESIVE COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE Nissan Chemical Corporation (JP) 2025-11-26 EP disclosed
US-20060241278-A1 Novel triarylamine polymer, process for producing the same, and use thereof TOSOH CORPORATION (JP) 2006-10-26 US disclosed
US-20060017040-A9 Novel triarylamine polymer, process for producing the same, and use thereof SUZUKI TAKAO 2006-01-26 US disclosed
CN-1680366-A Bidentate ligand and its iridium complex and electroluminescent device therewith UNIV WUHAN (CN) 2005-10-12 CN disclosed
US-20050147843-A1 carbazole phenylpyridine metal complexes or conjugated with additional polymers, for use in a light-emitting device; light emission from triplet excited state SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-07-07 US disclosed
EP-1528074-A1 NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Tosoh Corporation (JP) 2005-05-04 EP disclosed
US-20050031899-A1 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2005-02-10 US disclosed
US-20040262574-A1 Novel triarylamine polymer, process for producing the same, and use thereof TOSOH CORPORATION (JP) 2004-12-30 US disclosed
CN-1011236-B SYNTHETIC METHOD OF N-ALKYL SUBSTITUTED COMPOUND OF HETEROCYCLIC IMINES UNIV SHANXI (CN) 1991-01-16 CN disclosed
CN-86107063-A The synthetic method of N-alkyl substituted compound of heterocyclic imines 1988-04-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050031899-A1 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device GNA11, GNAO1, NOD1 MAPT 4375/4885KDM4E 4195/4885MEN1 1890/4885
US-20260098188-A1 RELEASE AGENT COMPOSITION FOR LIGHT IRRADIATION RELEASE, AND ADHESIVE COMPOSITION FOR LIGHT IRRADIATION RELEASE ERCC1, SMC2, SMC3 MAPT 1894/4885KDM4E 2909/4885MEN1 4133/4885
US-20260011598-A1 RELEASE AGENT COMPOSITION FOR PHOTOIRRADIATION RELEASE, LAMINATE, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE CBLC, PRRC2C, SMARCC2 MAPT 749/4885KDM4E 706/4885MEN1 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.